Narrow search
Showing 1 - 10 of 79
Cover Image
The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia--Volume I: Summary
Grootendorst, Paul V.; Dolovich, Lisa R.; Holbrook, Anne M. - Department of Economics, McMaster University - 2002
different active ingredients to a fixed "reference price". The setting of the reference price varies by jurisdiction but …
Persistent link: https://www.econbiz.de/10005763258
Cover Image
The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia--Volume III: ACE and CCB Literature Review
Dolovich, Lisa R.; Holbrook, Anne M.; Woodruff, Margaret - Department of Economics, McMaster University - 2002
(see SEDAP 70 for abstract)
Persistent link: https://www.econbiz.de/10005763264
Cover Image
The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia -- Volume III: ACE and CCB Literature Review
Dolovich, Lisa R.; Holbrook, Anne M.; Woodruff, Margaret - Department of Economics, McMaster University - 2002
(see QSEP 369 for abstract)
Persistent link: https://www.econbiz.de/10005181106
Cover Image
The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia -- Volume I: Summary
Grootendorst, Paul V.; Dolovich, Lisa R.; Holbrook, Anne M. - Department of Economics, McMaster University - 2002
different active ingredients to a fixed "reference price". The setting of the reference price varies by jurisdiction but …
Persistent link: https://www.econbiz.de/10005181109
Cover Image
The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia -- Volume II: Technical Report
Grootendorst, Paul V.; Dolovich, Lisa R.; Holbrook, Anne M. - Department of Economics, McMaster University - 2002
(see QSEP 369 for abstract)
Persistent link: https://www.econbiz.de/10005181110
Cover Image
The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia--Volume II: Technical Report
Grootendorst, Paul V.; Dolovich, Lisa R.; Holbrook, Anne M. - Department of Economics, McMaster University - 2002
(see SEDAP 70 for abstract)
Persistent link: https://www.econbiz.de/10005404416
Cover Image
The Impact of Differential Cost Sharing of Non-Steroidal Anti-Inflammatory Agents on the Use and Costs of Analgesic Drugs
Grootendorst, Paul V.; Marshall, John K.; Holbrook, Anne M. - Department of Economics, McMaster University - 2004
OBJECTIVE: To estimate the effect of differential cost sharing (DCS) schemes for non-steroidal anti-inflammatory drugs (NSAIDs) on drug subsidy program and beneficiary expenditures. DATA SOURCES/STUDY SETTING: Monthly aggregate claims data from Pharmacare, the public drug subsidy program for...
Persistent link: https://www.econbiz.de/10005404447
Cover Image
Health-Care Utilization in Canada: 25 Years of Evidence
Curtis, Lori J.; MacMinn, William J. - Department of Economics, McMaster University - 2007
An abundance of literature links socio-economic status to health and health care in Canada and other countries. Recent anecdotal evidence indicates that Canadians believe their access to health care is diminishing over time. This study provides a brief description of utilization patterns in...
Persistent link: https://www.econbiz.de/10005763301
Cover Image
Public and Private Health Care Financing with Alternate Public Rationing
Cuff, Katherine; Hurley, Jeremiath; Mestelman, Stuart; … - Department of Economics, McMaster University - 2007
We develop a model to analyze health care nancing arrangements and under alternative public sector rationing rules. Health care is demanded by individuals varying in income and severity of illness. There is a limited supply of health care resources used to treat individuals, causing some...
Persistent link: https://www.econbiz.de/10005763358
Cover Image
Effects of 'Authorized-Generics' on Canadian Drug Prices
Grootendorst, Paul - Department of Economics, McMaster University - 2007
This paper examines how the use of ‘authorized-generics’ (AGs) influences Canadian prescription drug prices. An authorized-generic is the actual brand name drug product, manufactured by the brand firm, but sold as a generic by a licensee or subsidiary of the brand, competing with independent...
Persistent link: https://www.econbiz.de/10005404411